Revier Therapeutics

Seed
revier.bio Biotech & Healthcare Heidelberg, Germany
Total Funding Undisclosed
Latest Round Undisclosed Seed
Last Announced Aug 25, 2026
Investors Undisclosed
Decision Makers Profile Active

About Revier Therapeutics

Revier Therapeutics develops small-molecule therapies for cardiometabolic diseases.

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Seed
Global Headquarters Heidelberg, Germany
Tracked Since Oct 2, 2026

Web & Domain Identity

Official Website revier.bio
Domain Registered Date Undisclosed

Social & Network Presence

X / Twitter Profile Not linked
LinkedIn Corporate Not linked

Company Milestones & Timeline

1 Events
  1. Capital Raise

    Seed announced

Investors & Backers

Investor firms and individual backers were not publicly disclosed in available round filings for Revier Therapeutics.

Funding History

1 Round
Seed · Aug 25, 2026
Undisclosed

Founders & Leadership

4

Eva van Rooij

Founder

Work email & phone locked Unlock →

Matthias Dewenter

Founder

Work email & phone locked Unlock →

Michael Nolan

Founder

Work email & phone locked Unlock →

Norbert Frey

Founder

Work email & phone locked Unlock →

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

START FREE WITH 50 CREDITS
Recently funded startups
New SaaS launches
Never pay twice for contacts